
Tilray Brands, Inc. — Investor Relations & Filings
Tilray Brands, Inc. is a global consumer packaged goods and cannabis-lifestyle company focused on enhancing wellbeing through innovative products. The company operates a diversified portfolio encompassing pharmaceutical, medical, and recreational cannabis, alongside consumer packaged goods, including beverages. Tilray is a leading producer of GMP-certified medical cannabis and holds the top market share position in the Canadian recreational cannabis sector. Leveraging advanced greenhouse cultivation and an extensive global supply chain, Tilray distributes a wide range of products—such as whole flower, vapes, and pre-rolls—across key markets in Canada, Europe, the United States, Australia, and Latin America.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Other.pdf | 2026-04-16 | English | |
| Other.pdf | 2026-04-01 | English | |
| 52-109F2 - Certification of interim filings - CEO (E).pdf | 2026-04-01 | English | |
| 52-109F2 - Certification of interim filings - CFO (E).pdf | 2026-04-01 | English | |
| 52-109F2 - Certification of interim filings - CEO (E).pdf | 2026-04-01 | English | |
| 52-109F2 - Certification of interim filings - CFO (E).pdf | 2026-04-01 | English |
Browse filings by year
9 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
|
AN2 Therapeutics, Inc.
Biopharmaceutical firm developing boron-based drugs for inf…
|
ANTX | US | Manufacturing |
|
Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicin…
|
ANAN | GB | Manufacturing |
|
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
Designs, develops, and manufactures molecular diagnostic so…
|
ANGEN | TR | Manufacturing |
|
ANAVEX LIFE SCIENCES CORP.
Clinical-stage biopharmaceutical company developing therape…
|
AVXL | US | Manufacturing |
|
Anbio Biotechnology
Develops and provides in-vitro diagnostic (IVD) solutions a…
|
NNNN | KY | Manufacturing |
|
Anebulo Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for acute canna…
|
ANEB | US | Manufacturing |
|
AnGes, Inc.
Biopharmaceutical firm developing gene-based and nucleotide…
|
4563 | JP | Manufacturing |
|
ANG Lifesciences India Limited
Develops and manufactures sterile dry powder and liquid inj…
|
540694 | IN | Manufacturing |
|
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.
Develops biopharmaceuticals, genetic engineering products, …
|
300009 | CN | Manufacturing |
Tilray Brands, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47621/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47621 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47621 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47621 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47621}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tilray Brands, Inc. (id: 47621)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.